--- title: "INSULET CORP (PODD) stock listing, news and investor profile" url: "https://aibio.space/companies/insulet/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "INSULET CORP (NASDAQ: PODD), United States. Listing facts, related biotech companies and news on aibio.space." --- PODD INSULET CORP NASDAQ · United States # INSULET CORP (PODD) news Debt Financing · 2026-09-21 ## [Insulet amends credit agreement, refinancing $475 million in term loans](https://aibio.space/news/insulet-amends-credit-agreement-refinancing-475-million-term-loans/) Morgan Stanley Senior Funding, Inc. is administrative agent. The margin on the refinanced term loans falls 0.25%, and cash and cash equivalents were $534.9 million at June 30, 2026, down from $716.1 million at the end of 2025. ## Latest INSULET CORP news We have not published a story on INSULET CORP yet. When there is news, it will appear here. ## INSULET CORP at a glance - **Ticker**: PODD - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $534.9 million ### Related companies - [NATURES SUNSHINE PRODUCTS INC](https://aibio.space/companies/natures-sunshine-products/) NASDAQ: NATR - [Inogen](https://aibio.space/companies/inogen/) NASDAQ: INGN - [Bioventus](https://aibio.space/companies/bioventus/) NASDAQ: BVS - [ARTIVION, INC.](https://aibio.space/companies/artivion/) NYSE: AORT - [Alphatec Holdings](https://aibio.space/companies/alphatec/) NASDAQ: ATEC - [NeuroPace](https://aibio.space/companies/neuropace/) NASDAQ: NPCE - [InspireMD](https://aibio.space/companies/inspiremd/) NASDAQ: NSPR - [GE HealthCare Technologies](https://aibio.space/companies/ge-healthcare-technologies/) NASDAQ: GEHC ### Also on NASDAQ - [Lucid Diagnostics](https://aibio.space/companies/lucid-diagnostics/) LUCD - [Cardiff Oncology](https://aibio.space/companies/cardiff-oncology/) CRDF - [TransMedics Group](https://aibio.space/companies/transmedics/) TMDX - [Dare Bioscience](https://aibio.space/companies/dare-bioscience/) DARE - [CDT Equity](https://aibio.space/companies/cdt-equity/) CDT - [Entera Bio](https://aibio.space/companies/entera-bio/) ENTX ## INSULET CORP annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$2.71 billion](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | [$2.07 billion](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | | Research and development | [$301.1 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | [$219.6 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | | Net income (loss) | [$247.1 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | [$418.3 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | | Cash from operations | [$569.3 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | [$430.2 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000028/) | | Cash and equivalents | [$716.1 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000169/) | [$953.4 million](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000169/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $534.9 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about INSULET CORP What is the ticker symbol of INSULET CORP? INSULET CORP trades under the ticker PODD on NASDAQ. Where is INSULET CORP listed? INSULET CORP is listed on NASDAQ. Which country or territory is INSULET CORP listed under? Our directory records INSULET CORP under United States. Does aibio.space cover INSULET CORP? aibio.space lists INSULET CORP among 2,820 public biotech companies and publishes its news here as stories appear. What was INSULET CORP's revenue last year? $2.71 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is INSULET CORP profitable? INSULET CORP reported net income of $247.1 million for the fiscal year ended Dec 31, 2025, and generated $569.3 million of cash from operations, per its annual report to the SEC. How much does INSULET CORP spend on research and development? $301.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does INSULET CORP have? $534.9 million in cash at Jun 30, 2026, per its 10-Q. What is the latest INSULET CORP (PODD) stock news? Our latest story on INSULET CORP, dated Sep 21, 2026: "Insulet amends credit agreement, refinancing $475 million in term loans". Morgan Stanley Senior Funding, Inc. is administrative agent. The margin on the refinanced term loans falls 0.25%, and cash and cash equivalents were $534.9 million at June 30, 2026, down from $716.1 million at the end of 2025. [Source](https://aibio.space/news/insulet-amends-credit-agreement-refinancing-475-million-term-loans/). Does INSULET CORP have debt, a term loan or convertible notes? Our latest debt story, dated Sep 21, 2026: "Insulet amends credit agreement, refinancing $475 million in term loans". Morgan Stanley Senior Funding, Inc. is administrative agent. The margin on the refinanced term loans falls 0.25%, and cash and cash equivalents were $534.9 million at June 30, 2026, down from $716.1 million at the end of 2025. [Source](https://aibio.space/news/insulet-amends-credit-agreement-refinancing-475-million-term-loans/). How can I follow INSULET CORP (PODD) news? Press Follow on this page to add INSULET CORP to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming INSULET CORP so far, in Debt Financing. ## Investor discussion: INSULET CORP Members talk about INSULET CORP (PODD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at INSULET CORP, newest first. Each line links the filing it comes from. 1. 2026-08-05 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1145197/000114519726000169/podd-20260630.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:PODD on TradingView](https://www.tradingview.com/symbols/NASDAQ-PODD/). ## Listing details INSULET CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PODD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: INSULET CORP - **Ticker**: PODD - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/insulet/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "INSULET CORP (PODD) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/insulet/